Patel Nupur U, Roach Catherine, Alinia Hossein, Huang William W, Feldman Steven R
Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC,
Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC.
Clin Cosmet Investig Dermatol. 2018 Aug 7;11:407-413. doi: 10.2147/CCID.S137527. eCollection 2018.
Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. While the goal of therapy is to treat the primary cause, cosmetic resolution of AN lesions can be important for patients and their quality of life. Treatment options for AN have not been extensively studied; however, smaller powered clinical trials and case reports exist in the literature. Our review aims to explore and evaluate the current treatment options that exist for AN.
黑棘皮病(AN)是一种全身性疾病常见的皮肤表现,与胰岛素抵抗、糖尿病、肥胖、内脏恶性肿瘤、内分泌紊乱及药物反应相关。AN的治疗主要集中于解决导致皮肤上出现天鹅绒样、色素沉着、角化过度斑块的潜在疾病过程。虽然治疗目标是治疗主要病因,但AN皮损的美容改善对患者及其生活质量可能很重要。针对AN的治疗选择尚未得到广泛研究;然而,文献中有一些小样本量的临床试验和病例报告。我们的综述旨在探索和评估目前存在的针对AN的治疗选择。